Metronomic Chemotherapy
A treatment approach using specific anticancer medicines in low doses on a planned schedule.
Metronomic chemotherapy is a treatment strategy that involves administering selected anticancer medicines at lower doses on a frequent or continuous schedule. It has been investigated as an approach for managing certain cancers and treatment settings.
Dr. Bhoor Singh Bhati has direct academic research experience in this area as Principal Investigator of a Phase II trial evaluating low-dose oral metronomic cyclophosphamide combined with etoposide in refractory endometrial cancer.
His research involvement reflects an interest in pragmatic and potentially accessible approaches to cancer treatment.
More treatments
Systemic Anticancer Therapy
Drug-based cancer treatment designed to manage malignancy beyond the primary tumour.
Oral Anticancer Therapy
Cancer medicines administered orally as part of selected treatment strategies.
Combination Anticancer Therapy
Using more than one therapeutic approach to address cancer through complementary treatment strategies.
Protocol-Based Cancer Treatment
Structured treatment guided by established oncology protocols and clinical evidence.
Personalised Treatment Planning
Individualised treatment planning based on cancer characteristics and patient-specific factors.
Treatment Response Assessment
Regular evaluation of how cancer responds to treatment during the course of care.
Cancer Treatment Toxicity Management
Monitoring and managing unwanted effects associated with cancer treatment